Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Owlet Inc. (OWLT) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Devices
$5.74
+0.88 (18.11%)Did OWLT Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Owlet is one of their latest high-conviction picks.
Based on our analysis of 7 Wall Street analysts, OWLT has a bullish consensus with a median price target of $13.50 (ranging from $13.00 to $15.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $5.74, the median forecast implies a 135.2% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for OWLT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 30, 2025 | Northland Capital Markets | Owen Rickert | Outperform | Maintains | $20.00 |
| Dec 9, 2025 | William Blair | Andrew Brackmann | Outperform | Initiates | $N/A |
| Nov 20, 2025 | Freedom Broker | Buy | Maintains | $N/A | |
| Feb 21, 2025 | Lake Street | Buy | Initiates | $8.50 | |
| Nov 16, 2022 | Citigroup | Jim Suva | Neutral | Maintains | $1.00 |
| Oct 20, 2022 | Cowen & Co. | Charles Rhyee | Outperform | Maintains | $4.00 |
| Sep 30, 2022 | B of A Securities | Allen Lutz | Neutral | Initiates | $1.50 |
| May 12, 2022 | Citigroup | Jim Suva | Neutral | Maintains | $3.25 |
| Oct 6, 2021 | Citigroup | Neutral | Maintains | $5.00 | |
| Oct 5, 2021 | B of A Securities | John Babcock | Neutral | Downgrade | $5.50 |
| Sep 8, 2021 | B of A Securities | Buy | Initiates | $N/A | |
| Aug 5, 2021 | Citigroup | Neutral | Initiates | $N/A | |
| Jul 26, 2021 | Cowen & Co. | Outperform | Initiates | $N/A |
The following stocks are similar to Owlet based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops innovative baby monitoring technology.
Owlet Inc. generates revenue by selling technologically advanced baby monitoring devices, such as the Smart Sock, which utilizes pulse oximetry to monitor infants' health metrics. The company's business model focuses on providing parents with peace of mind through real-time health analytics, creating a recurring need for its products in the health and wellness sector.
Owlet operates within the consumer electronics market, combining health technology with parental care. The company aims to expand its presence in North America and globally, leveraging data science to modernize traditional parenting tools and enhance digital health monitoring solutions for families.
Healthcare
Medical Devices
108
Mr. Kurt Workman
United States
2021
Owlet (OWLT) delivered earnings and revenue surprises of +50.00% and +9.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
KLA (KLAC) delivered earnings and revenue surprises of +2.60% and +0.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Owlet (OWLT) lacks the necessary factors for a probable earnings beat in its upcoming report. Investors should prepare for key expectations ahead.
Owlet's lack of key ingredients for an earnings beat may indicate weak financial performance, potentially impacting stock price and investor confidence.
Owlet, Inc. (NYSE: OWLT) will announce Q1 2026 financial results on May 7, 2026, after market close, followed by a conference call at 4:30 p.m. ET for updates.
Owlet's upcoming earnings announcement and conference call may impact stock performance, as investors will assess financial health and growth prospects in the smart infant monitoring market.
Owlet, Inc. (NYSE: OWLT) launched "Owlet for Orgs," an employer benefit program for new and expecting parents. VGM Group, Inc. is the first company to adopt this offering.
Owlet's new employer benefit program expands its market reach, potentially increasing revenue and customer base, which could positively impact stock performance and investor sentiment.
Owlet, Inc. (NYSE: OWLT) announced the resignation of CEO Jonathan Harris, effective immediately. Kurt Workman, co-founder and former CEO, will take over as CEO.
Leadership changes can impact investor confidence and stock performance. Kurt Workman's return may signal a strategic shift, influencing Owlet's direction and market perception.
Owlet, Inc. (NYSE: OWLT) announced its Dream Duo 3 was named 'Best for Monitoring Baby's Health' in the PARENTS 2026 Best for Baby Awards, highlighting its leadership in infant monitoring technology.
Owlet's recognition in the PARENTS Best for Baby Awards enhances its brand credibility, potentially boosting sales and investor confidence in its market position and growth prospects.
Owlet, Inc. (NYSE: OWLT) partners with Babylist for the 11th annual Make March Matter campaign, supporting Children's Hospital Los Angeles and promoting pediatric care.
Owlet's partnership with Babylist and support for Children's Hospital Los Angeles enhances brand reputation and community engagement, potentially driving sales and investor confidence.
Based on our analysis of 7 Wall Street analysts, Owlet Inc. (OWLT) has a median price target of $13.50. The highest price target is $15.00 and the lowest is $13.00.
According to current analyst ratings, OWLT has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.74. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict OWLT stock could reach $13.50 in the next 12 months. This represents a 135.2% increase from the current price of $5.74. Please note that this is a projection by Wall Street analysts and not a guarantee.
Owlet Inc. generates revenue by selling technologically advanced baby monitoring devices, such as the Smart Sock, which utilizes pulse oximetry to monitor infants' health metrics. The company's business model focuses on providing parents with peace of mind through real-time health analytics, creating a recurring need for its products in the health and wellness sector.
The highest price target for OWLT is $15.00 from at , which represents a 161.3% increase from the current price of $5.74.
The lowest price target for OWLT is $13.00 from at , which represents a 126.5% increase from the current price of $5.74.
The overall analyst consensus for OWLT is bullish. Out of 7 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $13.50.
Stock price projections, including those for Owlet Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.